Jan 9 (Reuters) - Briacell Therapeutics Corp BCT.V :
* BRIACELL OUTLINES NEW HIGH RESPONDING PATIENT GROUP ‘BIOMARKER' BASED ON CANCER GRADE
* BRIACELL THERAPEUTICS - HAS IDENTIFIED PATIENT POPULATION BIOMARKER WITH HIGH RATE OF CLINICAL BENEFIT FROM TREATMENTS BASED ON 'BREAST CANCER GRADE'